Home Elan in $1 billion royalty deal with Theravance
 

Keywords :   


Elan in $1 billion royalty deal with Theravance

2013-05-13 09:42:52| Biotech - Topix.net

Elan will make a once off payment of $1 billion to the company in exchange for a 21% stake in future royalty payments from four respiratory programmes which Theravance has developed with GlaxosmithKline.

Tags: with deal billion royalty

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
10.06Atlantic Tropical Weather Outlook
10.06Eastern North Pacific Tropical Weather Outlook
09.06Atlantic Tropical Weather Outlook
09.06Eastern North Pacific Tropical Weather Outlook
09.06Eastern North Pacific Tropical Weather Outlook
09.06Atlantic Tropical Weather Outlook
09.06Weekly Recap: Kimberly-Clark to Exit Nigeria, Ahlstrom Completes Brazilian Investment & More
09.06Tories promise 730m to end 'sick note culture'
More »